Total Neoadjuvant Treatment for Locally Advanced Rectal Cancer Patients: Where Do We Stand?

被引：8
|
作者：
Dapra, Valentina [1 ,2 ]
Airoldi, Marco [1 ,2 ]
Bartolini, Michela [1 ,2 ]
Fazio, Roberta [1 ,2 ]
Mondello, Giuseppe [2 ]
Tronconi, Maria Chiara [2 ]
Prete, Maria Giuseppina [2 ]
D'Agostino, Giuseppe [3 ]
Foppa, Caterina [1 ,4 ]
Spinelli, Antonino [1 ,4 ]
Puccini, Alberto [2 ]
Santoro, Armando [1 ,2 ]
机构：
[1] Humanitas Univ, Dept Biomed Sci, I-20072 Pieve Emanuele, Italy
[2] IRCCS Humanitas Res Hosp, Humanitas Canc Ctr, Med Oncol & Hematol Unit, I-20089 Rozzano, Italy
[3] IRCCS Humanitas Res Hosp, Radiotherapy & Radiosurg Dept, I-20089 Rozzano, Italy
[4] IRCCS Humanitas Res Hosp, Div Colon & Rectal Surg, I-20089 Rozzano, Italy
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2023年 / 24卷 / 15期
关键词：
locally advanced rectal cancer; total neoadjuvant therapy; rectal cancer; nonoperative management; ct-DNA; MMR-deficient tumor; TOTAL MESORECTAL EXCISION; SHORT-COURSE RADIOTHERAPY; METASTATIC COLORECTAL-CANCER; PHASE-III TRIAL; PREOPERATIVE RADIOTHERAPY; ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; OPEN-LABEL; POSTOPERATIVE CHEMORADIOTHERAPY; FOLLOW-UP;
D O I：
10.3390/ijms241512159
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The therapeutic landscape in locally advanced rectal cancer (LARC) has undergone a significant paradigm shift in recent years with the rising adoption of total neoadjuvant treatment (TNT). This comprehensive approach entails administering chemotherapy and radiation therapy before surgery, followed by optional adjuvant chemotherapy. To establish and deliver the optimal tailored treatment regimen to the patient, it is crucial to foster collaboration among a multidisciplinary team comprising healthcare professionals from various specialties, including medical oncology, radiation oncology, surgical oncology, radiology, and pathology. This review aims to provide insights into the current state of TNT for LARC and new emerging strategies to identify potential directions for future research and clinical practice, such as circulating tumor-DNA, immunotherapy in mismatch-repair-deficient tumors, and nonoperative management.
引用
收藏
页数：16
相关论文
共 50 条
  • [21] Neoadjuvant treatment of rectal cancer: where are we now?
    Kalyan, Aparna
    Rozelle, Shaina
    Benson, Al, III
    GASTROENTEROLOGY REPORT, 2016, 4 (03): : 206 - 209
  • [22] Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at?
    Yeh, Jen-Hao
    Yeh, Yung-Sung
    Tsai, Hsiang-Lin
    Huang, Ching-Wen
    Chang, Tsung-Kun
    Su, Wei-Chih
    Wang, Jaw-Yuan
    CANCERS, 2022, 14 (12)
  • [23] Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Where we Stand; An Italian Single Center Perspective
    Marino, Elisabetta
    Graziosi, Luigina
    Donini, Annibale
    IN VIVO, 2021, 35 (06): : 3459 - 3466
  • [24] Should Total Neoadjuvant Therapy Be the First-Line Treatment for Patients With Locally Advanced Rectal Cancer?
    Ali, Mahsoem
    Boyd, Lenka N. C.
    Giovannetti, Elisa
    Kazemier, Geert
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (08)
  • [25] Total neoadjuvant therapy for each locally advanced rectal cancer?
    Gudrun Piringer
    memo - Magazine of European Medical Oncology, 2024, 17 : 15 - 19
  • [26] Total Neoadjuvant Therapy protocol for locally advanced rectal cancer
    Romo Tapias, Leire
    Reta Decoreau, Idoya
    Rodriguez Sanchez, Angel
    Fernandez Trueba, Celia
    Arresti Sanchez, Jose Antonio
    Urquilla Ventura, Karla Berenice
    Flores Barrenechea, Lucia
    Ispizua Ojanguren, Maite
    Madrid Nebreda, Maria
    Labado Mora, Marta
    Carranza Pose, Marta
    Isabel Gnecchi, Marta
    Arguello Garcia, Miguel Antonio
    Briz Leon, Oriana
    Barrondo Azcorra, Victor Manuel
    Sierra Marin, Maider
    Fuertes Velez, Francisco Javier
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1529 - S1530
  • [27] Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
    Cercek, Andrea
    Roxburgh, Campbell S. D.
    Strombom, Paul
    Smith, J. Joshua
    Temple, Larissa K. F.
    Nash, Garrett M.
    Guillem, Jose G.
    Paty, Philip B.
    Yaeger, Rona
    Stadler, Zsofia K.
    Seier, Kenneth
    Gonen, Mithat
    Segal, Neil H.
    Reidy, Diane L.
    Varghese, Anna
    Shia, Jinru
    Vakiani, Efsevia
    Wu, Abraham J.
    Crane, Christopher H.
    Gollub, Marc J.
    Garcia-Aguilar, Julio
    Saltz, Leonard B.
    Weiser, Martin R.
    JAMA ONCOLOGY, 2018, 4 (06)
  • [28] Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer
    Gollins, S.
    Sebag-Montefiore, D.
    CLINICAL ONCOLOGY, 2016, 28 (02) : 146 - 151
  • [29] Intensifying neoadjuvant treatment in locally advanced rectal cancer
    Patel, Swapnil
    Kapoor, Akhil
    LANCET ONCOLOGY, 2021, 22 (07): : E301 - E301
  • [30] WHEN SHOULD WE OPERATE LOCALLY ADVANCED RECTAL CANCER AFTER NEOADJUVANT TREATMENT?
    Santos Rancano, R.
    Otero, J.
    Cerdan, C.
    Sanz, R.
    Sanz, G.
    Esteban, F.
    Mayol, J.
    Zuloaga, J.
    Serrano, I.
    Cerdan, J.
    BRITISH JOURNAL OF SURGERY, 2016, 103 : 10 - 10
12345